MergerLinks Daily Review
MergerLinks
Join a community of 250,000+ M&A professionals. Expand your network and discover new business opportunities.
Welcome to MergerLinks Daily Review. Sign up here to get the full round up of your daily dose of blue-chip M&A news directly to your inbox.
Hyundai aims to raise $3.3bn in record India IPO next week.
Germany said to tap Citi, Deutsche Bank and UBS for Uniper deal.
You can access today’s complete newsletter here.
Scroll down for more…
Ares Management Corporation , an American global alternative asset manager, agreed to acquire GCP International LLC , a global alternative asset management firm, from GLP Capital Partners , a global alternative asset manager investing in logistics, infrastructure and renewable energy assets, for $3.7bn.
"We have long admired the global real estate experience of GCP and its capabilities in facilitating the economy of the future, which includes investing in and managing industrial, data center and self-storage assets. As a combined business, we believe that Ares' and GCP International's experienced management teams, highly collaborative cultures and investment track records will create a powerhouse in global real assets investing," Michael Arougheti , Ares President and CEO.
GCP International is advised by 花旗 , 德意志银行 , Greenhill & Co. , 摩根士丹利 , 大华银行 and Kirkland & Ellis . Ares is advised by Barclays , Eastdil Secured , 高盛 , 富国银行 and Latham & Watkins (led by Alexandra Croswell Kelly , Owen Alexander and Daniel Breslin). GLP Capital Partners is advised by Gasthalter & Co. LP (led by Jonathan Gasthalter ).
ARCH Venture Partners , an American venture capital firm, led a $135m series A round in City Therapeutics , a biopharmaceutical company harnessing next-generation engineering of small interfering RNAs, with participation from Fidelity Wealth Management , Invus , Slate Path Capital LP , Rock Springs Capital , Regeneron Ventures and AN Ventures .
"As an early investor in Alnylam, ARCH supported the creation of RNAi medicines as a new frontier of medicine. The time to re-enter the RNAi revolution is now, and our investment in City Therapeutics is based on our conviction that RNAi therapeutics will expand as a major category of breakthrough medicines," Robert Nelsen, ARCH Venture Partners Co-Founder and Managing Director.
领英推荐
City Therapeutics was advised by 1AB (led by Katie Engleman ) and Precision AQ (led by Stephanie Ascher ).
Vivakor, Inc. , a remediation services company, completed the acquisition of Endeavor Crude, Meridian Equipment Leasing Equipment Transport and Silver Fuels Processing for $120m.
"The closing of the Endeavor Entities was a significant undertaking, with multiple business lines, spanning over six months in the making, culminating in Vivakor now owning one of the largest combined fleets of oilfield services in the continental United States. The integration and consolidation of existing operations creates immediate value within our financial framework, by delivering sustainable accretion to earnings that will result in increased shareholder value over time. We couldn't be more excited about this acquisition," James Ballengee , Vivakor Chairman, President, & CEO.
Hyundai aims to raise $3.3bn in record India IPO next week.
Hyundai Motor Company (?????) is seeking to raise as much as $3.3bn through an initial public offering of its Indian unit, kicking off the country’s biggest-ever listing, Bloomberg reported.
Hyundai Motor India set the price range at INR1,865 ($22) to INR1,960 per share. The price range was reported earlier in the day by Reuters.
Germany said to tap Citi, Deutsche Bank and UBS for Uniper deal.
Germany's government has selected banks to arrange a potential selldown of power company Uniper , which can be the biggest share sales in recent years, Bloomberg reported.
花旗 , 德意志银行 and 瑞银集团 have been appointed as joint global coordinators on the potential offering. More banks could be added to the lineup ahead of the share sale in the first quarter of next year.
Interested to find more? Sign up here to get full round up of your daily dose of blue-chip M&A news directly to your inbox.
You can access today’s complete newsletter here.